The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from

CardioComm Solutions Closes Equity Financing

Thursday, July 24, 2014

CardioComm Solutions Closes Equity Financing

14:53 EDT Thursday, July 24, 2014


TORONTO, ONTARIO / TNW-ACCESSWIRE / July 24, 2014 / CardioComm Solutions, Inc. (TSX VENTURE: EKG) ("CardioComm Solutions" or the "Company") announced today it had closed the first tranche of its previously announced private placement equity financing. Under the closing of the first tranche, the Company issued 3,300,000 units at a price of $0.05 per unit, for gross proceeds of $165,000. Each unit was comprised of one common share of the Company and one common share purchase warrant exercisable for two years for an additional share at a price of $0.07. For further information regarding the financing, please see the Company's press release that was issued on July 11, 2014. The gross proceeds from the financing will be used towards the development of next generation wireless ECG device products and expanded promotion of the GEMSTM WIN launch. The shares and warrants issued by the Company are subject to a four month hold period which expires on November 25, 2014. The Company also confirmed that it will continue its current private placement equity financing offer.

About CardioComm Solutions

CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Ontario, Canada, with offices in Victoria, B.C.


Etienne Grima, Chief Executive Officer

1-877-977-9425 x 227

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2014 TheNewswire - All rights reserved.

  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Secure Service
Customer Service
Advertising Privacy
Globe Recognition
Mobile Apps
Other Sections